Építés alatt – nem éles oldal
Belépés
Taking people in NorvégiaNo phase

Honest Open Proud for Psychotic and Bipolar Disorder in Norway

Key facts

Where
Oslo, NorvégiaSee the 2 sites

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

Forrás: NCT06384755: ki vehet részt

Where in Norvégia

  • Nydalen DPS, Division of Mental Health and Addiction, Oslo University HospitalOslo, NorvégiaTaking people
  • Søndre Oslo DPS, Division of Mental Health and Addiction, Oslo University HospitalOslo, NorvégiaToborzás még nem indult

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Oslo University Hospital
Trial code
NCT06384755
Record updated
2024. május 2.
Original description
The purpose of this pilot study is to evaluate the feasibility, acceptability and efficacy of a Norwegian adaptation of the group-based intervention 'Honest Open Proud' among adults with psychotic and bipolar disorders in an outpatient setting.Read full original descriptionShow less

Evaluation of a Norwegian Adaptation of the Honest Open Proud Program for Adults With Psychotic and Bipolar Disorders in an Outpatient Setting

The purpose of this pilot study is to evaluate the feasibility, acceptability and efficacy of a Norwegian adaptation of the group-based intervention 'Honest Open Proud' among adults with psychotic and bipolar disorders in an outpatient setting.

Inclusion: Diagnosed current psychotic (F 20) or bipolar disorder (F 30) according to International Classification of Diseases 10th Revision (ICD-10); Age 18 to 65; Ability to provide written informed consent; Fluent in Norwegian (needed for self-report measures); Experience difficulties with stigma and disclosure regarding mental illness.

Exclusion: Organic disorders; Intellectual disability.

ClinicalTrials.gov NCT06384755